|

SHY-ONC6 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • SHY Therapeutics1

Indications

  • Pancreatic Carcinoma Metastatic1
  • Hepatecellular Carcinoma1
  • Hormone-refractory Prostate Cancer1
  • HR+ Breast Cancer1
  • Advanced or Metastatic Solid Tumors1

Denver, Colorado1 trial

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

SCRI at HCA HealthONE

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.